Based on findings in our studies, next step pharmaceutical and clinical studies are warranted to design OXT analogs that have optimal therapeutic effects via peripheral administration to treat obesity, diabetes and related metabolic diseases. The gene discussed is OXT; the disease is Other metabolic disease.